US Patent 11555205 Recombinant arterivirus replicon systems and uses thereof
Patent 11555205 was granted and assigned to Janssen Pharmaceuticals on January, 2023 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
December 4, 2019
0
Date of Patent
January 17, 2023
0
Patent Applicant
Patent Application Number
16703359
0
Patent Inventor Names
Nathaniel Stephen Wang
0
Kurt Iver Kamrud
0
Martina Felderman
0
Nancy C. Carrico
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 11555205 Recombinant arterivirus replicon systems and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.